ALL leukemia
Selected indexed studies
- Leukemia's Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy. (Front Immunol, 2022) [PMID:35401520]
- Chronic lymphocytic leukaemia. (Crit Rev Oncol Hematol, 2016) [PMID:27370174]
- Revumenib: First Approval. (Drugs, 2025) [PMID:40072775]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Leukemia's Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy. (2022) pubmed
- Chronic lymphocytic leukaemia. (2016) pubmed
- Revumenib: First Approval. (2025) pubmed
- Multiparameter flow cytometry in the diagnosis and management of acute leukemia. (2011) pubmed
- Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. (1976) pubmed
- Advances in germline predisposition to acute leukaemias and myeloid neoplasms. (2021) pubmed
- GATA1-related leukaemias. (2008) pubmed
- The molecular and clinical significance of the Tie/angiopoietin system in leukemia. (2023) pubmed
- Type I interferons: leukemia's old foe in the limelight again. (2024) pubmed
- Targeting leukemia's "fatty tooth". (2015) pubmed